Mortality News and Research

RSS

New vaccine shows promise to fight Lassa virus

Researchers at the University of Texas Medical Branch have achieved success with a new vaccine developed to fight Lassa Virus, a pathogen that causes Lassa fever.

19 Jul 2022

CDC experts update on monkeypox in the United States

Scientists working with the CDC provide the latest information about monkeypox in the U.S.

19 Jul 2022

Study shows how a critical Lassa virus protein drives infection

Lassa fever is a viral illness that is far too common in West Africa. Although it can have a mortality rate of 15 percent in severe cases, up to 90% in pregnant women, and causes deafness in a quarter of survivors, there is no vaccine or antiviral to protect against Lassa virus.

19 Jul 2022

Elephant genes could offer new clues to preventing cancer development

Scientists modeling the cancer-suppressing p53 gene identify how the 20 different molecules unique to elephants get activated for increased sensitivity and response against carcinogenic conditions - with implications for cancer treatments in humans.

19 Jul 2022

What is the optimal alcohol consumption level to minimize health loss?

Researchers performed a population-scale analysis of alcohol consumption by amount, age, gender, region, and year to estimate the theoretical minimum risk exposure level (TMREL) and the non-drinker equivalence (NDE).

19 Jul 2022

Study finds decline in cardiovascular mortality rates over the last 20 years, but racial disparities remain

While it's well-established that Black adults experience a disproportionately high burden of cardiovascular risk factors and disease in comparison to white adults in the United States, few gender-based analyses of recent national trends exist.

19 Jul 2022

What is the efficacy of the second, third, and fourth dose of the COVID-19 mRNA vaccine?

Investigators examined the effectiveness of two, three, and four SARS-CoV-2 vaccine doses during the Omicron prevalent phases.

19 Jul 2022

Should siRNA-based antivirals be added to the COVID toolbox?

A recent study reviewed the existing treatment modalities, including vaccines and antivirals, for SARS-CoV-2 infection.

19 Jul 2022

Cardiovascular mortality has declined over the past two decades, but disparities persist

Research supported by the National Institutes of Health shows that cardiovascular-related deaths have declined over the past two decades, but disparities remain.

19 Jul 2022

Sex matters when it comes to immune responses to vaccines and viral infections

A review published in Frontiers in Aging analyzed the sex differences in the safety, effectiveness, and immunogenicity of influenza and COVID-19 vaccines in older individuals. It also analyzed the way sex brings about the modification of the impact of age-related factors on vaccination.

18 Jul 2022

Hospitalized COVID-19 patients with high blood viscosity have greater risk of death

Patients hospitalized with COVID-19 with high estimated blood viscosity are at higher risk of death from complications. High blood viscosity impairs flow to small vessels and increases the risk of blood clots. This measure of blood thickness can be used as a predictor of mortality.

18 Jul 2022

Infant formula marketing directly affects breastfeeding rates

Formula milk companies continue to defy international regulations and target health centers to market their products, a WHO study on formula marketing and its impact on breastfeeding shows.

18 Jul 2022

Researchers develop a cardiovascular disease risk score specific to the Latin American and Caribbean region

Researchers from the Latin American and Caribbean Cohort Consortium (CC-LAC) developed a risk algorithm specific to the Latin American and Caribbean region.

18 Jul 2022

Scientists develop an improved pharmaceutical drug for the treatment of atrial fibrillation

Scientists from the National University of Singapore Department of Pharmacy have developed an improved pharmaceutical drug for the treatment of the most common heart rhythm disturbance – atrial fibrillation (AF).

18 Jul 2022

Nitazoxanide drug found to be a potent inhibitor of several human coronaviruses

Researchers evaluated the activity of nitazoxanide against human coronaviruses (HCoVs).

18 Jul 2022

The pathobiology, host response, and effects of SARS-CoV-2 on the respiratory and intestinal microbiome

Researchers investigated the effect of influenza A virus pre-exposure and SARS-CoV-2 infection in the elderly population using a 14-month-aged golden Syrian hamsters model.

18 Jul 2022

The impact of glucocorticoid therapy on immune responses to COVID-19 vaccination or infection in rituximab-treated patients with autoimmune disorders

Researchers examined immune reactions to SARS-CoV-2)among B cell-depleted autoimmune patients who concomitantly administered glucocorticoids.

18 Jul 2022

Mortality News and Research

New vaccine shows promise to fight Lassa virus

CDC experts update on monkeypox in the United States

Study shows how a critical Lassa virus protein drives infection

Elephant genes could offer new clues to preventing cancer development

What is the optimal alcohol consumption level to minimize health loss?

Study finds decline in cardiovascular mortality rates over the last 20 years, but racial disparities remain

What is the efficacy of the second, third, and fourth dose of the COVID-19 mRNA vaccine?

Should siRNA-based antivirals be added to the COVID toolbox?

Cardiovascular mortality has declined over the past two decades, but disparities persist

Sex matters when it comes to immune responses to vaccines and viral infections

Hospitalized COVID-19 patients with high blood viscosity have greater risk of death

Infant formula marketing directly affects breastfeeding rates

Researchers develop a cardiovascular disease risk score specific to the Latin American and Caribbean region

Scientists develop an improved pharmaceutical drug for the treatment of atrial fibrillation

Nitazoxanide drug found to be a potent inhibitor of several human coronaviruses

The pathobiology, host response, and effects of SARS-CoV-2 on the respiratory and intestinal microbiome

The impact of glucocorticoid therapy on immune responses to COVID-19 vaccination or infection in rituximab-treated patients with autoimmune disorders

How effective is the fourth dose of COVID-19 vaccines in the elderly and long-term care residents?

How do different COVID-19 recovery paths impact health, food systems, and the environment?

Alcohol consumption does not provide any health benefits, presents many risks for young people

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News